PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsspasm
MeSH D013035 - spasm
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D020879:Neuromuscular manifestations
0 Companies
0 Drugs
Success rate
D013035: 
Spasm
110 Companies
16 Drugs
$
Success rate
D014313:Trismus
0 Companies
0 Drugs
Success rate
D019569:Hemifacial spasm
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Alembic PharmaceuticalsTizanidine Tizanidine  2020-01-13   
Alkem LaboratoriesTizanidine Tizanidine  2019-01-25   
AllerganCyclobenzaprine Cyclobenzaprine  1989-05-03   
1
2
3
4
5
6
...
11
>
Clinical Trials
Historical Success Rate
Phase 1
100%
2/2
Phase 2
57%
4/7
Phase 3
76%
13/17
Approved: 12Overall Success rate: 44%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Allergan
Aspirin
1
2
3
4
5
6
...
8
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use